The Blood and Marrow Transplant (BMT) and Hematologic Malignancies
program at St. Luke’s Cancer Institute is the first and only one of its kind in Idaho. Our patients receive the region’s most advanced therapies, with the benefit of care close to home.
Studies show that patient outcomes in community transplant programs, such as St. Luke’s Cancer Institute, are equal to those at academic medical centers. Moreover, our patients tell us that their quality of life is better because they’re able to stay close to home and family. We are committed to working with patients and physicians throughout every stage of the transplant process, and to returning patients home as soon as possible.
Since 1993, St. Luke's Cancer Institute has been performing autologous transplants (using the patient’s own stem cells) and syngeneic transplants (using cells from an identical twin). We also perform allogeneic transplants (using cells from a matched donor). Like other recognized centers around the country, our team uses mobilized peripheral blood stem cells in the transplant process. Our facility is a National Marrow Donor Program (NMDP) apheresis center.